A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
Clinical trial NCT05399888 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05399888
- Sponsor
- Biogen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-24
- Primary completion
- 2026-03-11
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.